These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 8349151)

  • 1. Uterine leiomyosarcoma and endometrial stromal sarcoma: lymph node metastases and sites of recurrence.
    Goff BA; Rice LW; Fleischhacker D; Muntz HG; Falkenberry SS; Nikrui N; Fuller AF
    Gynecol Oncol; 1993 Jul; 50(1):105-9. PubMed ID: 8349151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus.
    Leitao MM; Sonoda Y; Brennan MF; Barakat RR; Chi DS
    Gynecol Oncol; 2003 Oct; 91(1):209-12. PubMed ID: 14529683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome and prognosis in uterine sarcoma and malignant mixed Mullerian tumor.
    Burghaus S; Halmen S; Gass P; Mehlhorn G; Schrauder MG; Lux MP; Renner SP; Beckmann MW; Hein A; Thiel FC
    Arch Gynecol Obstet; 2016 Aug; 294(2):343-51. PubMed ID: 26711836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of current staging systems and a novel staging system for uterine leiomyosarcoma.
    Giuntoli RL; Lessard-Anderson CR; Gerardi MA; Kushnir CL; Cliby WA; Metzinger DS; Gostout BS
    Int J Gynecol Cancer; 2013 Jun; 23(5):869-76. PubMed ID: 23669444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic treatment in adult uterine sarcomas.
    Desar IME; Ottevanger PB; Benson C; van der Graaf WTA
    Crit Rev Oncol Hematol; 2018 Feb; 122():10-20. PubMed ID: 29458779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of lymph node metastasis on survival of women with uterine adenosarcoma.
    Machida H; Nathenson MJ; Takiuchi T; Adams CL; Garcia-Sayre J; Matsuo K
    Gynecol Oncol; 2017 Mar; 144(3):524-530. PubMed ID: 28109626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Real-World Study on Diagnosis and Treatment of Uterine Sarcoma in Western China.
    Li D; Yin N; Du G; Wang S; Xiao Z; Chen J; Chen W
    Int J Biol Sci; 2020; 16(3):388-395. PubMed ID: 32015676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors and outcome in women with uterine sarcoma.
    Denschlag D; Masoud I; Stanimir G; Gilbert L
    Eur J Surg Oncol; 2007 Feb; 33(1):91-5. PubMed ID: 17174517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine sarcoma: the Hacettepe hospital experience of 88 consecutive patients.
    Ayhan A; Tuncer ZS; Tanir M; Yüce K; Ayhan A
    Eur J Gynaecol Oncol; 1997; 18(2):146-8. PubMed ID: 9105869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uterine leiomyosarcoma and endometrial stromal sarcoma have unique miRNA signatures.
    Ravid Y; Formanski M; Smith Y; Reich R; Davidson B
    Gynecol Oncol; 2016 Mar; 140(3):512-7. PubMed ID: 26768834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
    Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
    Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors and survival of patients with uterine sarcoma: a German unicenter analysis.
    Huss A; Klar M; Hasanov MF; Juhasz-Böss I; Bossart M
    Arch Gynecol Obstet; 2023 Mar; 307(3):927-935. PubMed ID: 35780401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metastatic mechanisms of uterine malignancies and therapeutic consequences].
    Lax SF; Tamussino KF; Lang PF
    Pathologe; 2016 Nov; 37(6):549-556. PubMed ID: 27757531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study.
    Major FJ; Blessing JA; Silverberg SG; Morrow CP; Creasman WT; Currie JL; Yordan E; Brady MF
    Cancer; 1993 Feb; 71(4 Suppl):1702-9. PubMed ID: 8381710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine sarcoma in the south of Israel: study of 36 cases.
    Piura B; Rabinovich A; Yanai-Inbar I; Cohen Y; Glezerman M
    J Surg Oncol; 1997 Jan; 64(1):55-62. PubMed ID: 9040802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leiomyosarcoma: One disease or distinct biologic entities based on site of origin?
    Worhunsky DJ; Gupta M; Gholami S; Tran TB; Ganjoo KN; van de Rijn M; Visser BC; Norton JA; Poultsides GA
    J Surg Oncol; 2015 Jun; 111(7):808-12. PubMed ID: 25920434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease.
    Farid M; Ong WS; Tan MH; Foo LS; Lim YK; Chia WK; Soh LT; Poon D; Lee MJ; Ho ZC; Jeevan R; Chin F; Teo M; Quek R
    Am J Clin Oncol; 2013 Aug; 36(4):368-74. PubMed ID: 22772425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial stromal sarcomas with unusual histologic features: a report of 24 primary and metastatic tumors emphasizing fibroblastic and smooth muscle differentiation.
    Yilmaz A; Rush DS; Soslow RA
    Am J Surg Pathol; 2002 Sep; 26(9):1142-50. PubMed ID: 12218570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD146 as an adverse prognostic factor in uterine sarcoma.
    Zhou Y; Huang H; Yuan LJ; Xiong Y; Huang X; Lin JX; Zheng M
    Eur J Med Res; 2015 Aug; 20(1):67. PubMed ID: 26293576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and prognosis analysis of uterine sarcoma: a single-institution retrospective study.
    Wang F; Dai X; Chen H; Hu X; Wang Y
    BMC Cancer; 2022 Oct; 22(1):1050. PubMed ID: 36207687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.